Agoracom: Small Cap Investment - Zenith Epigenetics - Re: AGM - Jan 7, 2016

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

longtimerzen

Rank: Mail Room [?]

Points: 146 [?]

Votes: 5 Score: 3.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: AGM - Jan 7, 2016 - Details

in response to

Re: AGM - Jan 7, 2016 - Details

Toinv

posted on Jan 12, 2016 09:37PM

Share Liquidity

Don has done a 180-degree turn regarding a TSX listing. At least Don admitted his 180 AND at least he is considering a listing.

He is also suggesting a back door NASDAQ listing via a take over of one of the ailing resource companies that already has a NASDAQ listing. (come on?????...really). If so, I sure hope he has some specific targets in mind and that this is not just fantasy. It could be very interesting if it works.